Investing.com - Vaxart reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Vaxart announced earnings per share of $-0.230 on revenue of $50K. Analysts polled by Investing.com anticipated EPS of $-0.240 on revenue of $75K.
Vaxart shares are down 16% from the beginning of the year , still down 82.90% from its 52 week high of $8.13 set on Tuesday, November 30, 2021.
Vaxart follows other major Healthcare sector earnings this month
Vaxart's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar